2006•Chinese Journal of Hospital PharmacyRequires access

Study on preparation and in vitro drug release of actarit solid lipid nanoparticles

Zhou Xuefeng, Meng Xiang-shang, Na Zhang

Open publisher page 0 citations

Abstract

OBJECTIVE To prepare Actarit solid lipid nanoparticles(A-SLN)and to study the in vitro drug release behavior.METHODS Based on the result of single-factor experiments,4 factors were selected to search the best formulation and the best preparation routes with orthogonal experiments.The diameters and the zeta potential were measured.TEM was used to observe the particles shapes.And study the in vitro drug release rate.RESULTS The drug entrapment efficiency(EE%) was detected.The mean particle size was found to be 120 nm with a narrow particle distribution of polydispersity index,(0.233).The zeta potential of the A-SLN which was produced by the best formulation was(17.14) mV and the drug entrapment efficiency was(51.20%). The in vitro drug release rate profile could be described by equation 100Q=(38.536)t~(1/4)-(16.859)(r=(0.999 0))(0~12 h) and 100Q=(13.907)t~(1/4)+(28.32)(r=(0.999 2))(13~648 h).CONCLUSION A-SLN with sustained release property could be achieved by solvent emuldification / evaporation method.

About this research paper

What this paper is about

OBJECTIVE To prepare Actarit solid lipid nanoparticles(A-SLN)and to study the in vitro drug release behavior.METHODS Based on the result of single-factor experiments,4 factors were selected to search the best formulation and the best preparation routes with orthogonal experiments.The diameters and the zeta potential were measured.TEM was used to observe the particles shapes.And study the in vitro drug release rate.RESULTS The drug entrapment efficiency(EE%) was detected.The mean particle size was found to be 120 nm with a narrow particle distribution of polydispersity index,(0.233).The zeta potential of the A-SLN which was produced by the best formulation was(17.14) mV and the drug entrapment efficiency was(51.20%). The in vitro drug release rate profile could be described by equation 100Q=(38.536)t~(1/4)-(16.859)(r=(0.999 0))(0~12 h) and 100Q=(13.907)t~(1/4)+(28.32)(r=(0.999 2))(13~648 h).CONCLUSION A-SLN with sustained release property could be achieved by solvent emuldification / evaporation method.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To prepare Actarit solid lipid nanoparticles(A-SLN)and to study the in vitro drug release behavior.METHODS Based on the result of single-factor experiments,4 factors were selected to search the best formulation and the best preparation routes with orthogonal experiments.The diameters and the zeta potential were measured.TEM was used to observe the particles shapes.And study the in vitro drug release rate.RESULTS The drug entrapment efficiency(EE%) was detected.The mean particle size was found to be 120 nm with a narrow particle distribution of polydispersity index,(0.233).The zeta potential of the A-SLN which was produced by the best formulation was(17.14) mV and the drug entrapment efficiency was(51.20%). The in vitro drug release rate profile could be described by equation 100Q=(38.536)t~(1/4)-(16.859)(r=(0.999 0))(0~12 h) and 100Q=(13.907)t~(1/4)+(28.32)(r=(0.999 2))(13~648 h).CONCLUSION A-SLN with sustained release property could be achieved by solvent emuldification / evaporation method.

Key concepts: Zeta potential, Solid lipid nanoparticle, Dispersity, Particle size, Drug, Chromatography, Chemistry, In vitro

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on preparation and in vitro drug release of actarit solid lipid nanoparticles — Research Paper | ScholarLens